Skip to main content
SpringerLink
Log in

Evidence-based Anticancer Materia Medica for Nasopharyngeal Carcinoma

  • Chapter
  • First Online:
Materia Medica for Various Cancers

Part of the book series: Evidence-based Anticancer Complementary and Alternative Medicine ((ACAM,volume 2))

Abstract

Nasopharyngeal carcinoma (NPC) is a unique malignancy with a distinct racial and geographical distribution. The most incidences of NPC occur in the Southern China, North Africa, and Mediterranean basin. Chemoradiotherapy is acknowledged as the standard treatment option for the vast majority of patients with locoregionally immediate and/or advanced NPC. One drawback to this aggressive therapy is the development of systemic acute mucosal and hematologic toxicity. Therefore, the pursuit of additional novel and effective drugs and therapeutic strategies for NPC is critical to improve the quality of life (QoL) of NPC patients. Herbal medicines have been shown to be effective in treating and preventing many diseases, including NPC. Accumulating evidence demonstrates the potential of herbal medicines to care for NPC patients during and after major conventional treatments. Herbal medicine has been shown to minimize adverse effects, enhance the curative effects, improve QoL and immunity, and prolong the survival period of NPC patients. To date, at least 16 herbs have exhibited their therapeutic effects as both concomitant and adjuvant treatment for patients with NPC. However, more controlled trials are needed to determine the role of herbal medicines in NPC therapy, not only for the efficacy, but also for the feasibility, safety, and costs associated with the treatment alternative. This chapter focuses on the anticancer effects of herbal medicines in managing NPC. Furthermore, the rationale and mechanisms of herbal medicine in NPC therapy are also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • AJCC, American Joint Committee on Cancer (1997) Manual for staging of cancer. 5th edition, JB Lippincott, Philadelphia.

    Google Scholar 

  • Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T et al (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 16:1310–1317

    PubMed  CAS  Google Scholar 

  • Altundag K, Aksoy S, Gullu I, Altundag O, Ozyar E, Yalcin S et al (2004) Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with cisplatin-based chemotherapy. Med Oncol 21:211–215

    Article  PubMed  CAS  Google Scholar 

  • Arango BA, Castrellon AB, Perez CA, Raez LE, Santos ES (2010) Nasopharyngeal carcinoma: alternative treatment options after disease progression. Expert Rev Anticancer Ther 10:377–386

    Article  PubMed  Google Scholar 

  • Bao YX, Wong CK, Leung SF, Chan AT, Li PW, Wong EL et al (2006) Clinical studies of immunomodulatory activities of Yunzhi-Danshen in patients with nasopharyngeal carcinoma. J Altern Complement Med 12:771–776

    Article  PubMed  Google Scholar 

  • Baujat B, Audry H, Bourhis J, Chan AT, Onat H, Chua DT et al (2006) Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys 64:958–959

    Google Scholar 

  • Blaskovich MA, Sun J, Cantor A, Turkson J, Jove R, Sebti SM (2003) Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Res 63:1270–1279

    PubMed  CAS  Google Scholar 

  • Bo W, Rensheng W, Li S (2010) Cost-effectiveness analysis of sarcandra glabra on reducing radioacbive xerostomia in patients with nasopharyngeal carcinoma. J Guangxi Med Univ 27:247–250

    Google Scholar 

  • Caponigro F, Longo F, Ionna F, Perri F (2010) Treatment approaches to nasopharyngeal carcinoma: a review. Anticancer Drugs 21:471–477

    Article  PubMed  CAS  Google Scholar 

  • Chan AT (2010) Nasopharyngeal carcinoma. Ann Oncol 21(Suppl 7):vii308–vii312

    Article  PubMed  Google Scholar 

  • Chan AT, Felip E (2009) Nasopharyngeal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20:123–125

    PubMed  Google Scholar 

  • Chan AT, Teo PM, Johnson PJ (2002a) Nasopharyngeal carcinoma. Ann Oncol 13:1007–1015

    Article  PubMed  CAS  Google Scholar 

  • Chan AT, Teo PM, Ngan RK, Leung TW, Lau WH, Zee B et al (2002b) Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol 20:2038–2044

    Article  PubMed  CAS  Google Scholar 

  • Chan AT, Hsu MM, Goh BC, Hui EP, Liu TW, Millward MJ et al (2005) Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma. J Clin Oncol 23:3568–3576

    Article  PubMed  CAS  Google Scholar 

  • Chang ET, Adami HO (2006) The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 15:1765–1777

    Article  PubMed  CAS  Google Scholar 

  • Chen JS, Cao XB, Zhan YZ, Jiang YS, Ye MS (2003) The clinical observation on berberine treating nasopharyngeal carcinoma patients with leukopenia caused by radiotherapy and chemiotherapy. Chin J Nat Med 5:80–82

    Google Scholar 

  • Chen Y, Liu MZ, Liang SB, Zong JF, Mao YP, Tang LL et al (2008) Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of China. Int J Radiat Oncol Biol Phys 71:1356–1364

    Article  PubMed  Google Scholar 

  • Cheng SH, Tsai SY, Yen KL, Jian JJ, Chu NM, Chan KY et al (2000) Concomitant radiotherapy and chemotherapy for early-stage nasopharyngeal carcinoma. J Clin Oncol 18:2040–2045

    PubMed  CAS  Google Scholar 

  • Cho WC (2010) Scientific evidence on the supportive cancer care with Chinese medicine. Zhongguo Fei Ai Za Zhi 13:190–194

    PubMed  Google Scholar 

  • Cho WC, Chen HY (2009) Clinical efficacy of traditional Chinese medicine as a concomitant therapy for nasopharyngeal carcinoma: a systematic review and meta-analysis. Cancer Invest 27:334–344

    Article  PubMed  CAS  Google Scholar 

  • Cho WC, Leung KN (2007a) In vitro and in vivo immunomodulating and immunorestorative effects of Astragalus membranaceus. J Ethnopharmacol 113:132–141

    Article  PubMed  Google Scholar 

  • Cho WC, Leung KN (2007b) In vitro and in vivo anti-tumor effects of Astragalus membranaceus. Cancer Lett 252:43–54

    Article  PubMed  CAS  Google Scholar 

  • Chong VF, Ong CK (2008) Nasopharyngeal carcinoma. Eur J Radiol 66:437–447

    Article  PubMed  CAS  Google Scholar 

  • Chua DT, Sham JS, Kwong DL, Au GK (2003) Treatment outcome after radiotherapy alone for patients with stage I–II nasopharyngeal carcinoma. Cancer 98:74–80

    Article  PubMed  Google Scholar 

  • Chua DT, Nicholls JM, Sham JS, Au GK (2004) Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 59:11–20

    Article  PubMed  CAS  Google Scholar 

  • Clement-Kruzel S, Hwang SA, Kruzel MC, Dasgupta A, Actor JK (2008) Immune modulation of macrophage pro-inflammatory response by goldenseal and Astragalus extracts. J Med Food 11:493–498

    Article  PubMed  CAS  Google Scholar 

  • Deng MQ, Mai HQ, Mai WY, Mo HY, Huang XM, Guo X et al (2008) Endoscopic microwave coagulation therapy for locally recurrent nasopharyngeal carcinoma. Chin J Cancer 27:57–59

    Google Scholar 

  • Gao QT, Cheung JKH, Li J, Chu GKY, Duan R, Cheung AWH et al (2006) A Chinese herbal decoction, Danggui Buxue Tang, prepared from Radix Astragali and Radix Angelicae Sinensis stimulates the immune responses. Planta Med 72:1227–1231

    Article  PubMed  CAS  Google Scholar 

  • Guigay J (2008) Advances in nasopharyngeal carcinoma. Curr Opin Oncol 20:264–269

    Article  PubMed  Google Scholar 

  • Han SY, Li PP (2009) Progress of research in antitumor mechanisms with Chinese medicine. Chin J Integr Med 15:316–320

    Article  PubMed  Google Scholar 

  • Hannigan A, Wilson JB (2010) Evaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition. Mol Cancer 9:184

    Article  PubMed  Google Scholar 

  • Hareyama M, Sakata K, Shirato H, Nishioka T, Nishio M, Suzuki K et al (2002) A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Cancer 94:2217–2223

    Article  PubMed  CAS  Google Scholar 

  • Hassen E, Nahla G, Bouaouina N, Chouchane L (2010) The human leukocyte antigen class I genes in nasopharyngeal carcinoma risk. Mol Biol Rep 37:119–126

    Article  PubMed  CAS  Google Scholar 

  • He XY, Hu CS, Ying HM, Wu YR, Zhu GP, Liu TF (2010) Paclitaxel with cisplatin in concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma. Eur Arch Otorhinolaryngol 267:773–778

    Article  PubMed  Google Scholar 

  • Hildesheim A, West S, De Veyra E, Guzman MF D, Jurado A, Imai J, Hinuma Y et al (1992) Herbal medicine use, Epstein-Barr virus, and risk of nasopharyngeal carcinoma. Cancer Res 52:3048–3051

    PubMed  CAS  Google Scholar 

  • Hu QY, Liu P, Wang L, Fu ZF (2007) Concurrent chemoradiotherapy followed by adjuvant chemotherapy for stage III–IVa nasopharyngeal carcinoma. Ai Zheng 26:394–397

    PubMed  Google Scholar 

  • Huang P, Deng H, Zhao M (2000) Inhibition of the expression of Epstein-Barr virus antigens in vitro by Chinese medicine compound “ Dongxia wan”. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 14:128–130

    PubMed  CAS  Google Scholar 

  • Huang GX, Zhao C, Han F, Zhang B, Qiu HJ, Xu BP et al (2003a) Clinical study in prophylactic use of chinese medicine to prevent chemoradiotherapy induced mucositis in nasopharyngeal carcinoma. Ai Zheng 22:1084–1087

    PubMed  Google Scholar 

  • Huang GX, Zhang B, Qiu HJ, Xu BP, Chen XX, Hu PL (2003b) Chinese medicine in the treatment of acute radiation oropharyngitis in patients with nasopharyhgeal carcinoma. Zhong Shan Da Xue Xue Bao 24:S1–S4

    Google Scholar 

  • Huang ST, Wang CY, Yang RC, Chu CJ, Wu HT, Pang JH (2009) Phyllanthus urinaria increases apoptosis and reduces telomerase activity in human nasopharyngeal carcinoma cells. Forsch Komplementmed 16:34–40

    Article  PubMed  Google Scholar 

  • Hui EP, Ma BB, Leung SF, King AD, Mo F, Kam MK et al (2009) Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. J Clin Oncol 27:242–249

    Article  PubMed  CAS  Google Scholar 

  • Ianovski I, Izzard M, Morton RP, Plank LD (2010) Nasopharyngeal carcinoma: differences in presentation between different ethnicities in the New Zealand setting. ANZ J Surg 80:254–257

    Article  PubMed  Google Scholar 

  • Imai S, Sugiura M, Mizuno F et al (1994) African Burkitt’s lymphoma: a plant, Euphorbia tirucalli reduces Epstein-Barr virus-specific cellular immunity. Anticancer Res 14:933–936

    PubMed  CAS  Google Scholar 

  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

    Google Scholar 

  • Kapadia GJ, Azuine MA, Tokuda H, Hang E, Mukainaka T, Nishino H et al (2002) Inhibitory effect of herbal remedies on 12-o-tetradecanoylphorbol-13-acetate-promoted Epstein-Barr virus early antigen activation. Pharmacol Res 45:213–220

    Article  PubMed  CAS  Google Scholar 

  • Khabir A, Sellami M, Sakka M, Ghorbel AM, Daoud J, Jlidi R et al (2000) Contrasted frequencies of p53 accumulation in the two age groups of North African nasopharyngeal carcinomas. Clin Cancer Res 6:2932–2936

    Google Scholar 

  • Koon H, Leung AW, Yue KK, Mak NK (2006) Photodynamic effect of curcumin on NPC/CNE2 cells. J Environ Pathol Toxicol Oncol 25:205–215

    PubMed  CAS  Google Scholar 

  • Langendijk JA, Leemans CR, Buter J, Berkhof J, Slotman BJ (2004) The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature. J Clin Oncol 22:4604–4612

    Article  PubMed  CAS  Google Scholar 

  • Lee AW, Tung SY, Chua DT, Ngan RK, Chappell R, Tung R et al (2010) Randomized trial of radiotherapy plus concurrent¨Cadjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 102:1188–1198

    Article  PubMed  Google Scholar 

  • Li F, Guan Y, Chen Z (2008) Visions & reflections (minireview) proteomics in nasopharyngeal carcinoma. Cell Mol Life Sci 65:1007–1012

    Article  PubMed  CAS  Google Scholar 

  • Lin JC, Jan JS, Hsu CY, Liang WM, Jiang RS, Wang WY (2003) Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol 21:631–637

    Article  PubMed  Google Scholar 

  • Lin AS, Shibano M, Nakagawa-Goto K, Tokuda H, Itokawa H, Morris-Natschke SL et al (2008a) Cancer preventive agents. 7. Antitumor-promoting effects of seven active flavonolignans from milk thistle (Silybum marianum) on Epstein-Barr virus activation. Pharm Biol 45:735–738

    Article  Google Scholar 

  • Lin JC, Cherng JM, Hung MS, Baltina LA, Baltina L, Kondratenko R (2008b) Inhibitory effects of some derivatives of glycyrrhizic acid against Epstein-Barr virus infection: structure-activity relationships. Antiviral Res 79:6–11

    Article  PubMed  CAS  Google Scholar 

  • Lin ZH, Xia HP, Fu M, Liao WM, Lin T, Chen XG et al (2008c) Study on effect of sho-saiko-to compound on growth of nasopharyngeal carcinoma cells in CNE-bearing nude mice. Zhongguo Zhong Yao Za Zhi 33:2670–2674

    PubMed  Google Scholar 

  • Lin YT, Wang LF, Hsu YC (2009) Curcuminoids suppress the growth of pharynx and nasopharyngeal carcinoma cells through induced apoptosis. J Agric Food Chem 57:3765–3770

    Article  PubMed  CAS  Google Scholar 

  • Liu SJ, Tian DF, He YC, Zeng L, Huang C, Liu YQ (2007) Correlation of Ca2+ current features of nasopharyngeal carcinoma cells with different metastatic potentiality to their moving abilities. Ai Zheng 26:473–479

    PubMed  CAS  Google Scholar 

  • Liu SJ, Sun YM, Tian DF, He YC, Zeng L, He Y et al (2008) Downregulated NM23-H1 expression is associated with intracranial invasion of nasopharyngeal carcinoma. Br J Cancer 98:363–369

    Article  PubMed  CAS  Google Scholar 

  • Liu LF, Wang JM, Zhao LQ, Nilsen J, McClure K, Wong K et al. (2009) Progesterone increases rat neural progenitor cell cycle gene expression and proliferation via extracellularly regulated kinase and progesterone receptor membrane components 1 and 2. Endocrinology 150:3186–3196

    Article  PubMed  CAS  Google Scholar 

  • Lui VW, Yau DM, Wong EY, Ng YK, Lau CP, Ho Y et al (2004) Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma. Head Neck 26:389–395

    Article  PubMed  Google Scholar 

  • Lui VW, Yau DM, Wong EY, Ng YK, Lau CP, Ho Y et al (2009) Cucurbitacin I elicits anoikis sensitization, inhibits cellular invasion and in vivo tumor formation ability of nasopharyngeal carcinoma cells. Carcinogenesis 30:2085–2094

    Article  PubMed  CAS  Google Scholar 

  • Mai HQ, Zeng ZY, Feng KT, Ye YL, Hong MH et al (2006) Therapeutic targeting of the endothelin a receptor in human nasopharyngeal carcinoma. Cancer Sci 97:1388–1395

    Article  PubMed  CAS  Google Scholar 

  • Morrison JA, Klingelhutz AJ, Raab-Traub J (2003) Epstein-Barr virus latent membrane protein 2A activates b-catenin signaling in epithelial cells. J Virol 77:12276–12284

    Article  PubMed  CAS  Google Scholar 

  • Mould RF, Tai TH (2002) Nasopharyngeal carcinoma: treatments and outcomes in the 20th century. Br J Radiol 75:307–339

    PubMed  CAS  Google Scholar 

  • Park K, Lee JH (2007) Photosensitizer effect of curcumin on UVB-irradiated HaCaT cells through activation of caspase pathways. Oncol Rep 17:537–540

    PubMed  CAS  Google Scholar 

  • Popat SR, Liavaag PG, Morton R, McIvor N, Irish JC, Freeman JL (2000) Epstein Barr virus genome in nasopharyngeal carcinomas from New Zealand. Head Neck 22:505–508

    Article  PubMed  CAS  Google Scholar 

  • Razak AR, Siu LL, Le Tourneau C (2010) Molecular targeted therapies in all histologies of head and neck cancers: an update. Curr Opin Oncol 22:212–220

    Article  PubMed  CAS  Google Scholar 

  • Shair KH, Schnegg CI, Raab-Traub N (2008) EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration. Cancer Res 68:6997–7005

    Article  PubMed  CAS  Google Scholar 

  • Sharma A, Mohanti BK, Thakar A, Bahadur S, Bhasker S (2010) Concomitant chemoradiation versus radical radiotherapy in advanced squamous cell carcinoma of oropharynx and nasopharynx using weekly cisplatin: a phase II randomized trial. Ann Oncol 21:2272–2277

    Article  PubMed  CAS  Google Scholar 

  • Song PR, Qiu BS, Wu YT (2007) Clinical observation on TCM treatment according to syndrome differentiation in relieving acute radio-reaction in nasopharyngeal carcinoma patients. Zhongguo Zhong Xi Yi Jie He Za Zhi 27:452–455

    PubMed  Google Scholar 

  • Straathof KC, Bollard CM, Popat U, Huls MH, Lopez T, Morriss MC et al (2005) Treatment of nasopharyngeal carcinoma with Epstein-Barr virus-specific T lymphocytes. Blood 105:1898–1904

    Article  PubMed  CAS  Google Scholar 

  • Swart R, Ruf IK, Sample J, Longnecker R (2000) Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-kinase/AKT pathway. J Virol 74:10838–10845

    Article  PubMed  CAS  Google Scholar 

  • Tang ZY, Tu QS (2005) Clinical observation on effect of supplemented shengmai san (SMS) to acute radioactive reaction of nasopharyngeal carcinoma (NPC). Chin Med Eng 13:398–440

    Google Scholar 

  • Tang FQ, Tian DF, Chen ZH (2001) Inhibitory effect of yiqijiedu powder to telomerase and telomerase RNA in nasopharyngeal tumorigenesis of rats. Hunan Yi Ke Da Xue Xue Bao 26:301–304

    PubMed  CAS  Google Scholar 

  • Tang FQ, Wang DS, Duan CJ, Cao Y et al (2009) I Berberine inhibits metastasis of nasopharyngeal carcinoma 5-8F cells by targeting Rho kinase-mediated Ezrin phosphorylation at Threonine 567. J Biol Chem 248:26456–26466

    Google Scholar 

  • Tao X, Sun J, Jiang YZ (2007) Mechanism of Chinese medicine herbs in the radiotherapy of nosopharyngeal carcinoma. Chin Arch Tradit Chin Med 25:351–353

    Google Scholar 

  • Tsang CM, Lau EP, Di K, CHeung PY, Hau PM, Ching YP et al (2009) Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells. Int J Mol Med 24:131–138

    PubMed  CAS  Google Scholar 

  • Wan XB, Fan XJ, Chen MY, Liu QT (2009) Inhibition of Aurora-A results in increased cell death in 3-dimensional culture microenvironment, reduced migration and is associated with enhanced radiosensitivity in human nasopharyngeal carcinoma. Cancer Biol Ther 8:1500–1506

    Article  PubMed  CAS  Google Scholar 

  • Wang Q, Liu H, Qiao N (1998) Effects of traditional Chinese medicine on salivary glands in the patients with head and neck cancer during radiotherapy. Zhongguo Zhong Xi Yi Jie He Za Zhi 18:662–664

    PubMed  CAS  Google Scholar 

  • Wang RS, Liu WQ, Li J, Zhang Y, Qin YT (2003) Accelerated fractionated radiotherapy with concurrent chemotherapy in advanced nasopharyngeal carcinoma. Ai Zheng 22:982–984

    PubMed  Google Scholar 

  • Wang ZY, Li GS, Huang HX (2006) Clinical observation on treatment of 75 mid-late stage cancer patients with yanshu Injection. Zhongguo Zhong Xi Yi Jie He Za Zhi 26:681–684

    PubMed  CAS  Google Scholar 

  • Wang MK, Ding LS, Wu FE (2008) Antitumor effects of raddeanin a on S180, H22 and U14 cell xenografts in mice. Ai Zheng 27:910–913

    PubMed  CAS  Google Scholar 

  • Wang P, Xu C, Xu J, Wang X, Leung AW (2010a) Hypocrellin B enhances ultrasound-induced cell death of nasopharyngeal carcinoma cells. Ultrasound Med Biol 36:336–342

    Article  PubMed  Google Scholar 

  • Wang X, Xia X, Xu C, Xu J, Wang P, Xiang J et al (2010b) Ultrasound-induced cell death of nasopharyngeal carcinoma cells in the presence of curcumin. Integr Cancer Ther XX:1–7

    Google Scholar 

  • Wee J, Tan EH, Tai BC, Wong HB, Leong SS, Tan T et al (2005) Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 23:6730–6738

    Article  PubMed  CAS  Google Scholar 

  • Weng XY, Ma RD, Yu LJ (2003) Apoptosis of human nasopharyngeal carcinoma CNE-2Z cells induced by tubeimoside I. Ai Zheng 22:806–811

    PubMed  Google Scholar 

  • Xia YS, Wang JH, Liu X, Jin XQ (2002) A comparative study on the long-term effects of radiotherapy combined with herbs of blood circulation-promoting and healthy qistrengthening on nasopharyngeal carcinoma. Chin J Otolaryngol Integr Tradit West Med 10:72–74

    Google Scholar 

  • Xie FY, Zeng ZF, Huang HY, Zhao C, Lu TX (2001) Clinical observation on nasopharyngeal carcinoma treated with combined therapy of radiotherapy and ginseng polysaccharide injection. Zhongguo Zhong Xi Yi Jie He Za Zhi 21:332–334

    PubMed  CAS  Google Scholar 

  • Xu L, Lao LX, Ge A, Yu S, Li J, Mansky PJ (2007) Chinese herbal medicine for cancer pain. Integr Cancer Ther 6:208–234

    Article  PubMed  Google Scholar 

  • Yamashiki M, Nishimura A, Huang XX, Nobori T, Sakaguchi S, Suzuki H (1999) Effects of the Japanese Herbal Medicine (TJ-9) on Interleukin-12 production in patients with HC-positive liver cirrhosis. Dev Immunol 7:17–22

    Article  PubMed  CAS  Google Scholar 

  • Yan WP, Chen LH, Xu ZX, Deng XG (2003) Etiological analysis of the sequelae of radiotherapy for nasopharyngeal carcinoma: a follow-up study of 112 cases. Di Yi Jun Yi Da Xue Xue Bao 23:1002–1005

    PubMed  Google Scholar 

  • Yang LF, Xiao LB, Ma XQ, Tang M, Cao Y et al (2009) Effect of DNAzymes targeting Akt1 on cell proliferation and apoptosis in nasopharyngeal carcinoma. Cancer Biol Ther 8:366–371

    PubMed  CAS  Google Scholar 

  • Yu SZ, Yang GH, Feng JM (2006) Clinical study on treatment of malignant neoplasms with Shenqi Fuzheng injection and chemotherapy. Zhong Xi Yi Jie He Xue Bao 4:84–86

    Article  PubMed  Google Scholar 

  • Yuan J, Zhang Z, Xiao JY (2000) Efficacy of radiotherapy combined with Traditional Chinese medicine (TCM) in NPC patients. Hunan Yi Ke Da Xue Xue Bao 25:254–256

    PubMed  CAS  Google Scholar 

  • Zhang SF, Wang XC, Chen Z (2007) Clinical research of traditional Chinese medicine in treatment of toxic and adverse reactions of radiotherapy for malignant tumor: current status. Zhong Xi Yi Jie He Xue Bao 5:470–474

    Article  PubMed  Google Scholar 

  • Zhang MH, Li XY, Zhang YF, Zhuo KY (2010) Bax inhibitor-1 mediates apoptosis-resistance in human nasopharyngeal carcinoma cells. Mol Cell Biochem 333:1–7

    Article  PubMed  CAS  Google Scholar 

  • Zhao D, Liu XJ, Xie Q, Huang ZP, Zou BX, Ge YB (2006) Intensity-modulated radiation combined with Delisheng injection for naspharyngeal carcinoma. Nan Fang Yi Ke Da Xue Xue Bao 26:874–875

    PubMed  Google Scholar 

  • Zheng JX, Zhou TC, Xu K, Li LN (2006) Effect of Selaginella combined with radiotherapy on nasopharyngeal carcinoma. Nan Fang Yi Ke Da Xue Xue Bao 26:247–248

    PubMed  Google Scholar 

  • Zheng J, Wang G, Yang GY, Wang D, Luo X, Chen C et al (2010) Induction chemotherapy with Nedaplatin with 5-FU followed by intensity-modulated radiotherapy concurrent with chemotherapy for locoregionally advanced nasopharyngeal carcinoma. Jpn J Clin Oncol 40:425–431

    Article  PubMed  Google Scholar 

  • Zhu X, Wang A, Wang S (2000) Clinical study on effect of combined treatment with shenlong oral liquid and radiotherapy in treating nasopharyngeal carcinoma. Zhongguo Zhong Xi Yi Jie He Za Zhi 20:818–820

    PubMed  CAS  Google Scholar 

  • Zhu XF, Xie BF, Zhou JM, Feng GK, Liu ZC, Wei XY et al (2005) Blockade of vascular endothelial growth factor receptor signal pathway and antitumor activity of ON-III (2’,4’-dihydroxy-6’-methoxy-3’,5’-dimethylchalcone), a component from Chinese herbal medicine. Mol Pharmacol 67:1444–1450

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Life Science, Ningxia University, Yinchuan, Ningxia, 750021, PR China

    Guangcun Deng, Jihui Yang & Yujiong Wang

Authors
  1. Guangcun Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jihui Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yujiong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yujiong Wang .

Editor information

Editors and Affiliations

  1. Queen Elizabeth Hospital, Department of Clinical Oncology, Room 1305, 13/F, Block R, Gascoigne Road 30, Kowloon, Hong Kong, China, People's Republic

    William C.S. Cho

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Deng, G., Yang, J., Wang, Y. (2012). Evidence-based Anticancer Materia Medica for Nasopharyngeal Carcinoma. In: Cho, W. (eds) Materia Medica for Various Cancers. Evidence-based Anticancer Complementary and Alternative Medicine, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-1983-5_13

Download citation

Publish with us

Policies and ethics

Search

Navigation